Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × idecabtagene vicleucel × Clear all

Phase

Status

Completed 5 Active not recruiting 4 Recruiting 3 Terminated 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Cyclophosphamide 387 Carboplatin 336 Gemcitabine 328 Cisplatin 323 pembrolizumab 322 Radiotherapy 295 Paclitaxel 293 Docetaxel 283 Bevacizumab 250 Rituximab 233 Capecitabine 221 Nivolumab 215 Dexamethasone 202 Fluorouracil 188 fludarabine 175 Oxaliplatin 174 Doxorubicin 153 Irinotecan 148 Pemetrexed 147 Leucovorin 142 Etoposide 142 Cytarabine 131 Bortezomib 128 fludarabine phosphate 126 Cetuximab 126 Lenalidomide 123 Erlotinib Hydrochloride 120 Filgrastim 119 Temozolomide 113 Radiosurgery 111

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04855136 2025-09-11

KarMMa-7

Celgene

Phase 1/2 Terminated

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡